Moderna Wants Claims In COVID-19 Vax Patent Suit Tossed

By Dave Simpson · May 23, 2022, 10:56 PM EDT

Moderna Inc. urged a Delaware federal court to nix several claims from an infringement suit claiming it used technology Alnylam Pharmaceuticals Inc. developed that ensures the mRNA in COVID-19 vaccines safely...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief

Case Information

Case Title

Alnylam Pharmaceuticals, Inc. v. Moderna, Inc., et al

Case Number

Court

Delaware

Nature of Suit

Patent

Date Filed

March 17, 2022

Case Title

Alnylam Pharmaceuticals, Inc. v. Pfizer Inc., et al

Case Number

Court

Delaware

Nature of Suit

Patent

Date Filed

March 17, 2022

Recent Articles By Dave

January 30, 2023
Feds Call Convicted Theranos COO Balwani A 'Flight Risk'
December 14, 2022
Health Net Hit With $14.4M Verdict Over Surgery Delay
December 13, 2022
DeSantis Petitions Fla. Justices For COVID-19 Vax Grand Jury
December 12, 2022
Juul To Pay Pa. $38.8M To Settle Youth Marketing Claims
December 05, 2022
Pfizer, BioNTech Seek To Nix Moderna Vax IP Suit, Countersue
December 02, 2022
Doctor Repped By RFK Jr. Targets COVID Misinformation Law
November 18, 2022
DOJ Will Ask DC Circ. To Block UnitedHealth-Change Deal
November 17, 2022
Akin Gump Gets Green Light To Represent Endo Claimants
November 04, 2022
SF-Walgreens Opioid Trial Called Off Amid Settlement Talks
October 31, 2022
Direct HIV Med Buyers Seek OK Of $10.8M Bristol-Myers Deal